Page last updated: 2024-10-18

dihydroxyphenylalanine and Cortical Lewy Body Disease

dihydroxyphenylalanine has been researched along with Cortical Lewy Body Disease in 5 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research Excerpts

ExcerptRelevanceReference
"Braak's staging concept of Lewy body disease pathogenesis is based on a spatiotemporal sequence of alpha-synuclein deposition, with autonomic nervous system involvement before synucleinopathy in substantia nigra neurons."3.78Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy. ( Goldstein, DS; Holmes, C; Park, MY; Sewell, L; Sharabi, Y, 2012)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klein, JC1
Eggers, C1
Kalbe, E1
Weisenbach, S1
Hohmann, C1
Vollmar, S1
Baudrexel, S1
Diederich, NJ1
Heiss, WD1
Hilker, R1
Salazar, G1
Cuello, D1
Fragoso, M1
Benlloc, L1
Goldstein, DS1
Holmes, C1
Sewell, L1
Park, MY1
Sharabi, Y1
Hu, XS1
Okamura, N1
Arai, H1
Higuchi, M1
Matsui, T1
Tashiro, M1
Shinkawa, M1
Itoh, M1
Ido, T1
Sasaki, H1
Hisanaga, K1
Suzuki, H1
Tanji, H1
Mochizuki, H1
Iwasaki, Y1
Sato, N1
Jin, K1

Other Studies

5 other studies available for dihydroxyphenylalanine and Cortical Lewy Body Disease

ArticleYear
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
    Neurology, 2010, Mar-16, Volume: 74, Issue:11

    Topics: Acetylcholine; Aged; Brain; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18;

2010
Neuropsychiatric symptoms in Lewy body diffuse disease: a case report.
    Neurologia (Barcelona, Spain), 2011, Volume: 26, Issue:8

    Topics: Aged; Antidepressive Agents; Cognition Disorders; Depressive Disorder, Major; Dihydroxyphenylalanine

2011
Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2012, Volume: 22, Issue:1

    Topics: Aged; alpha-Synuclein; Autonomic Denervation; Dementia; Dihydroxyphenylalanine; Disease Progression;

2012
18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies.
    Neurology, 2000, Nov-28, Volume: 55, Issue:10

    Topics: Aged; Aged, 80 and over; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Kinetics; Lewy B

2000
Fluoro-DOPA and FDG positron emission tomography in a case of pathologically verified pure diffuse Lewy body disease.
    Journal of neurology, 2001, Volume: 248, Issue:10

    Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonanc

2001